PRICE T ROWE ASSOCIATES INC /MD/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$478
+19.5%
159,290
-1.9%
0.00%
Q2 2023$400
-1.0%
162,436
-9.0%
0.00%
Q1 2023$404
-38.2%
178,440
-4.8%
0.00%
Q4 2022$654
-100.0%
187,459
-4.6%
0.00%
-100.0%
Q3 2022$7,278,000
+127.1%
196,556
+16.5%
0.00%
Q2 2022$3,205,000
-24.6%
168,757
+7.1%
0.00%
Q1 2022$4,253,000
+1915.6%
157,565
+1855.6%
0.00%
Q3 2021$211,000
-95.8%
8,057
-93.8%
0.00%
-100.0%
Q4 2019$5,049,000129,4610.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders